Purple Biotech Ltd
PPBT
$2.97
$0.051.54%
NASDAQ
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -- | 83.71% | 79.05% | 63.58% | |
| Total Depreciation and Amortization | -- | -7.18% | -8.04% | -5.58% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | -16.09% | -132.76% | -477.71% | |
| Change in Net Operating Assets | -- | -623.68% | -479.34% | -1,681.02% | |
| Cash from Operations | -- | 50.10% | 40.54% | 27.89% | |
| Capital Expenditure | -- | -300.00% | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -67.79% | -71.45% | -97.08% | |
| Cash from Investing | -- | -67.95% | -71.45% | -96.33% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -5.14% | -11.70% | -8.93% | |
| Issuance of Common Stock | -- | 366.85% | 398.31% | 401.41% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -120.54% | -121.66% | -121.71% | |
| Cash from Financing | -- | 18.54% | 21.20% | 24.32% | |
| Foreign Exchange rate Adjustments | -- | 35.00% | -750.00% | -107.41% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | 83.26% | 64.59% | -1,210.17% | |